Cargando…
Enhanced immune response induced by P5 HER2/neu‐derived peptide‐pulsed dendritic cells as a preventive cancer vaccine
Dendritic cells are special and powerful antigen‐presenting cells that can induce primary immune responses against tumour‐associated antigens. They can present antigens via both MHC‐I and MHC‐II, so they have the ability to stimulate both cytotoxic T lymphocytes and T helper cells. Furthermore, CD8(...
Autores principales: | Gholizadeh, Zahra, Tavakkol‐Afshari, Jalil, Nikpoor, Amin Reza, Jalali, Seyed Amir, Jaafari, Mahmoud Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742681/ https://www.ncbi.nlm.nih.gov/pubmed/28944998 http://dx.doi.org/10.1111/jcmm.13343 |
Ejemplares similares
-
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
por: Razazan, Atefeh, et al.
Publicado: (2017) -
A Case-Control Study on the p73 G4A Gene Polymorphism and Susceptibility to Breast Cancer in an Iranian Population
por: TAVAKKOL AFSHARI, Zeinab, et al.
Publicado: (2019) -
Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
por: Yazdani, Mona, et al.
Publicado: (2021) -
Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice
por: Ghaffari-Nazari, Haniyeh, et al.
Publicado: (2015) -
Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects
por: Shariat, Sheida, et al.
Publicado: (2015)